Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10
Zanin-Zhorov, Alexandra, Weiss, Jonathan M, Trzeciak, Alissa, Chen, Wei, Zhang, Jingya, Nyuydzefe, Melanie S, Arencibia, Carmen, Polimera, Seetharam, Schueller, Olivier, Fuentes-Duculan, Judilyn, Bonifacio, Kathleen M, Kunjravia, Norma, Cueto, Inna, Soung, Jennifer, Fleischmann, Roy M, Kivitz, Alan, Lebwohl, Mark, Nunez, Margarita, Woodson, Johnnie, Smith, Shondra L, West, Robert F, Berger, Mark, Krueger, James G, Ryan, John L, Waksal, Samuel D
Published in The Journal of immunology (1950) (15.05.2017)
Published in The Journal of immunology (1950) (15.05.2017)
Get full text
Journal Article
Selective oral ROCK2 inhibitor reduces clinical scores in patients with Psoriasis Vulgaris and normalizes skin pathology via concurrent regulation of IL-17 and IL-10 levels
Zanin-Zhorov, Alexandra, Weiss, Jonathan M, Trzeciak, Alyssa, Chen, Wei, Zhang, Jingya, Nyuydzefe, Melanie, Arencibia, Carmen, Polimera, Seetharam, Fuentes-Duculan, Judilyn, Bonifacio, Kathleen, Kunjravia, Norma, Cueto, Inna, Berger, Mark, Krueger, James, Ryan, John L, Waksal, Samuel D
Published in The Journal of immunology (1950) (01.05.2017)
Published in The Journal of immunology (1950) (01.05.2017)
Get full text
Journal Article